Antacids Market 2021-2027 Trends, Research Report, Growth Trends, Opportunities, and Forecast to 2027

In 2017, the global antacid market size was valued at $5.83 billion and is projected to expand at a CAGR of 3% during the forecast period. Changes in eating habits are one of the major factors expected to drive growth over the forecast period.

The increasing prevalence of gastroesophageal reflux disease (GERD) is expected to impact the overall market during the forecast period. According to the journal Gut published by the International Foundation for Gastrointestinal Disorders, in 2017 the prevalence of GERD was approximately 18% to 28% in North America, 9% to 26% in Europe, and 3% to 8% in East Asia. , from 9% to 33% in the Middle East, 12% in Australia and 23% in South America.

Global Antacids Market Segmentation

By Formulation Type

 

• Tablet
• Powder
• Others

 

By Distribution Channel

 

• Hospital Pharmacies
• E-Commerce
• Others

Major Players

 

• GlaxoSmithKline PLC
• Sun Pharmaceuticals Ltd
• Sanofi S.A
• Bayer AG
• Johnson & Johnson

 

 Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume

 

Recent Developments

• Market Overview and growth analysis
• Import and Export Overview
• Volume Analysis
• Current Market Trends and Future Outlook
• Market Opportunistic and Attractive Investment Segment

 

Key Questions Answered Global Antacids Market Report

• What was the Global Antacids Market in 2021 and 2021; what are the estimated growth trends and market forecast (2021-2027).
• What will be the CAGR of Global Antacids Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2018? How these segments are are expected to grow during the forecast period (2021-2027)?
• Which manufacturer/vendor/players in the Global Antacids Market was the market leader in 2018?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.